DEA-MATE Training for Acute Care Clinicians

CME Information

Date of Original Release: June 3, 2024. Date of most recent review: May 10, 2024. Termination date: October 1, 2026.

Accreditation: EB Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation: EB Medicine designates this enduring material for a maximum of 8 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Specialty CME: Included as part of the 8 credits, this CME activity is eligible for 4 substance use disorders, 3 controlled substances, and 2 pharmacology CME credits, subject to your state and institutional requirements. This CME activity is eligible for 8 credit hours toward the United States Department of Justice Drug Enforcement Administration Medication Access and Training Expansion (MATE) requirements. For more information, call Customer Service at 678-366-7933.

AOA Accreditation: This activity is eligible for 8 Category 2-B credit hours by the American Osteopathic Association.

Needs Assessment: The need for this educational activity was determined by a survey of medical staff, including the

editorial board of these publications; review of morbidity and mortality data from the CDC, AHA, NCHS, and ACEP; and evaluation responses from prior educational activities for emergency physicians.

Target Audience: This enduring material is designed for emergency medicine physicians, physician assistants, nurse practitioners.

Goals: Upon completion of this activity, you should be able to: (1) identify areas in practice that require modification to be consistent with current evidence in order to improve competence and performance; (2) develop strategies to accurately diagnose and treat both common and critical ED presentations; and (3) demonstrate informed medical decision-making based on the strongest clinical evidence.

CME Objectives: Upon completion of this activity, you should be able to: (1) recognize acute presentations of commonly used substances in adolescent patients; (2) discuss the role and limitations of diagnostic testing in suspected illicit substance use; and (3) identify and manage common and life-threatening complications of frequently used substances. (4) describe the signs and symptoms of opioid overdose and opioid withdrawal in emergency department (ED) patients; (5) list the medication options for managing ED patients with opioid overdose or withdrawal, their phar-macokinetics, and dosing; and (6) explain how to offer and initiate medications for opioid use disorder in the ED, taking into account the patient’s wishes and social situation.

Discussion of Investigational Information: As part of the activity, faculty may be presenting investigational information about pharmaceutical products that is outside Food and Drug Administration approved labeling. Information presented as part of this activity is intended solely as continuing medical education and is not intended to promote off-label use of any pharmaceutical product.

Disclosure: It is the policy of EB Medicine to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME activities. All individuals in a position to control content have disclosed all financial relationships with ACCME-defined ineligible companies. EB Medicine has assessed all relationships with ineligible companies disclosed, identified those financial relationships deemed relevant, and appropriately mitigated all relevant financial relationships based on each individual’s role(s). Please find disclosure information for this activity below:

Planners

• Daniel J. Egan, MD (Course Director): Nothing to Disclose
• Ilene Claudius, MD (Editor-in-Chief): Nothing to Disclose
• Tim Horeczko, MD (Editor-in-Chief): Nothing to Disclose
• Andy Jagoda, MD (Editor-in-Chief):
  • Pfizer (Consultant/Advisor)
  • Janssen (Consultant/Advisor)
  • Abbott Laboratories (Consultant/Advisor)
• Kaushal Shah, MD (Associate Editor-in-Chief): Nothing to Disclose

Faculty

• Abha H. Athale, DO, MSc (Author): Nothing to Disclose
• Michael J. Stoner, MD (Author): Nothing to Disclose
• Corey S. Hazekamp, MD, MS (Author): Nothing to Disclose
• Dana Sacco, MD, MSc (Author): Nothing to Disclose
• Vincent Calleo, MD (Peer Reviewer): Nothing to Disclose
• Jonathan R. Eisenberg, MD (Peer Reviewer): Nothing to Disclose
• Patrick Maher, MD, MS (Peer Reviewer): Nothing to Disclose
• Brian G. Wiener, MD (Peer Reviewer): Nothing to Disclose
• Aimee Mishler, PharmD (Pharmacology Editor): Nothing to Disclose
• Brian Skrainka, MD (CME Question Editor): Nothing to Disclose
• Joseph D. Toscano, MD (Research Editor): Nothing to Disclose
• Dorothy Whisenhunt, MS (Content Editor): Nothing to Disclose
• Cheryl Belton, PhD (Content Editor): Nothing to Disclose

Commercial Support: This issue of Emergency Medicine Practice did not receive any commercial support.

Earning Credit: (1) Go online to www.ebmedicine.net/CME and click on the title of the test you wish to take. When completed, a CME certificate will be emailed to you.

Additional Policies: For additional policies, including our statement of conflict of interest, source of funding, statement of informed consent, and statement of human and animal rights, visit https://www.ebmedicine.net/policies.